Prevalence of hypercalcemia of malignancy among pediatric cancer patients in the UK Clinical Practice Research Datalink database

BACKGROUND: The reported proportion of cancer patients who experience hypercalcemia of malignancy (HCM) is low, particularly in the pediatric population, ranging between <1% and 5%. HCM can be observed with any type of tumor in children and occurs most commonly with leukemia. While HCM is a poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Jick, Susan, Li, Lin, Gastanaga, Victor M, Liede, Alexander, Hernandez, Rohini K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479301/
https://www.ncbi.nlm.nih.gov/pubmed/28670142
http://dx.doi.org/10.2147/CLEP.S137616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479301/
https://www.ncbi.nlm.nih.gov/pubmed/28670142
http://dx.doi.org/10.2147/CLEP.S137616

Ejemplares similares